Ticker AKUS – Akouos – sales, description, marketcap – Tickerday.com

AKUS

Akouos

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 698.76M; Volume: 92.91K; AvgVol 3m: 202.03K; Beta: –;

Cost estimate:

P/E: –; EPS: -0.93; EPS growth quarter/prev quarter: ;

EPS growth this year: -328.10%; EPS growth past 5 years: ;

EPS ttm: ;

P/S: ; P/B: 02.03; P/Cashflow: 2.13; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: ; ROE – return on equity: ; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 15.30%; Insider Transactions:0.00%;

Institutional Ownership: 81.40%; Institutional Transactions: ;

Data update: 07.10.2020.